+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Gastro-Intestinal Stromal Tumors Clinical Trial Pipeline Highlights - 2021

  • ID: 5236265
  • Report
  • January 2021
  • Region: Global
  • Fore Pharma
1 of 3
The latest report Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Gastro-Intestinal Stromal Tumors market. It covers emerging therapies for Gastro-Intestinal Stromal Tumors in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by the company.

Short-term Launch Highlights:
Find out which Gastro-Intestinal Stromal Tumors pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:
  • Gastro-Intestinal Stromal Tumors phase 3 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 2 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 1 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors preclinical research pipeline products
  • Gastro-Intestinal Stromal Tumors discovery stage pipeline products
  • Gastro-Intestinal Stromal Tumors pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Gastro-Intestinal Stromal Tumors Pipeline by Stages
2. Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trial Insights
3. Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trial Insights
4. Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trial Insights
5. Gastro-Intestinal Stromal Tumors Preclinical Research Insights
6. Gastro-Intestinal Stromal Tumors Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables
Table 1: Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trials, 2021
Table 2: Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trials, 2021
Table 3: Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trials, 2021
Table 4: Gastro-Intestinal Stromal Tumors Preclinical Research, 2021
Table 5: Gastro-Intestinal Stromal Tumors Discovery Stage, 2021

List of Figures
Figure 1: Gastro-Intestinal Stromal Tumors Pipeline Molecules by Clinical Trials Stage, 2021
Figure 2: Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trial Highlights, 2021
Figure 3: Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trial Highlights, 2021
Figure 4: Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trial Highlights, 2021
Figure 5: Gastro-Intestinal Stromal Tumors Preclinical Research Highlights, 2021
Figure 6: Gastro-Intestinal Stromal Tumors Discovery Stage Highlights, 2021
Note: Product cover images may vary from those shown
3 of 3
  • Global
  • Europe
  • US
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Japan
Note: Product cover images may vary from those shown
Adroll
adroll